Skip to main content

Centiva Capital, LP

Position in ADCT — ADC Therapeutics SA

CIK 1692507 New York, NY

Position in ADCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,920
New position
Shares Held
17,683
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 114 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Centiva Capital, LP holds $2,208,307 across 5 Drug Manufacturers - Specialty & Generic names. ADCT ranks #5 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ADCT
ADC Therapeutics SA
This page
17,683 $18,920

All Filings in ADCT

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $18,920 17,683